IL110755A0 - In vito growth of neutrophil and megakaryocyte precursors in serum-free media - Google Patents

In vito growth of neutrophil and megakaryocyte precursors in serum-free media

Info

Publication number
IL110755A0
IL110755A0 IL11075594A IL11075594A IL110755A0 IL 110755 A0 IL110755 A0 IL 110755A0 IL 11075594 A IL11075594 A IL 11075594A IL 11075594 A IL11075594 A IL 11075594A IL 110755 A0 IL110755 A0 IL 110755A0
Authority
IL
Israel
Prior art keywords
vito
neutrophil
serum
growth
free media
Prior art date
Application number
IL11075594A
Other versions
IL110755A (en
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of IL110755A0 publication Critical patent/IL110755A0/en
Publication of IL110755A publication Critical patent/IL110755A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0642—Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/44—Thiols, e.g. mercaptoethanol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/98—Xeno-free medium and culture conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
IL11075594A 1993-08-23 1994-08-23 In vitro growth of neutrophil and megakaryocyte precursors in serum-free media IL110755A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11027793A 1993-08-23 1993-08-23

Publications (2)

Publication Number Publication Date
IL110755A0 true IL110755A0 (en) 1994-11-11
IL110755A IL110755A (en) 2000-11-21

Family

ID=22332160

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11075594A IL110755A (en) 1993-08-23 1994-08-23 In vitro growth of neutrophil and megakaryocyte precursors in serum-free media

Country Status (7)

Country Link
EP (1) EP0719326A1 (en)
JP (1) JPH09505462A (en)
AU (1) AU702871B2 (en)
CA (1) CA2168091A1 (en)
IL (1) IL110755A (en)
SG (1) SG52619A1 (en)
WO (1) WO1995006112A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7144731B2 (en) 1989-10-16 2006-12-05 Amgen Inc. SCF antibody compositions and methods of using the same
US6248319B1 (en) 1989-10-16 2001-06-19 Krisztina M. Zsebo Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides
US6852313B1 (en) 1989-10-16 2005-02-08 Amgen Inc. Method of stimulating growth of melanocyte cells by administering stem cell factor
US6207454B1 (en) 1989-10-16 2001-03-27 Amgen Inc. Method for enhancing the effciency of gene transfer with stem cell factor (SCF) polypeptide
US9068164B1 (en) * 1995-02-02 2015-06-30 Tristem Trading (Cyprus) Limited Method of preparing an undifferentiated cell
AU6125396A (en) * 1995-06-07 1996-12-30 Novartis Ag Serum-free media for primitive hematopoietic cells and metho ds of use thereof
US6733746B2 (en) * 1996-03-12 2004-05-11 Invitrogen Corporation Hematopoietic cell culture nutrient supplement
EP2243827B2 (en) 1996-08-30 2017-11-22 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US6811776B2 (en) 2000-12-27 2004-11-02 The Regents Of The University Of Michigan Process for ex vivo formation of mammalian bone and uses thereof
CA2552229C (en) * 2003-12-26 2013-03-12 Miho Furue Basal medium for es cell culturing
JP4651282B2 (en) * 2004-01-21 2011-03-16 田辺三菱製薬株式会社 Method for amplifying hematopoietic stem cells and hematopoietic progenitor cells
US7923013B2 (en) 2004-12-28 2011-04-12 The Rockefeller University Glycolipids and analogues thereof as antigens for NKT cells
WO2006071848A2 (en) 2004-12-28 2006-07-06 The Rockefeller University Glycolipids and analogues thereof as antigens for nk t cells
US7837990B2 (en) 2005-03-28 2010-11-23 The Rockefeller University In vivo expanded NKT cells and methods of use thereof
AU2013202353B2 (en) * 2006-03-24 2015-05-07 Children's Medical Center Corporation Method to modulate hematopoietic stem cell growth
RU2493252C2 (en) 2006-03-24 2013-09-20 Чилдрен'З Медикал Сентер Корпорейшн Method to stimulate expansion of haematopoietic stem cells
AU2015207905B2 (en) * 2006-03-24 2017-04-27 Children's Medical Center Corporation Method to modulate hematopoietic stem cell growth
WO2008070310A2 (en) 2006-10-20 2008-06-12 Children's Medical Center Corporation Method to enhance tissue regeneration
WO2010091052A2 (en) 2009-02-03 2010-08-12 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
WO2010096264A2 (en) 2009-02-03 2010-08-26 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
JP2014523741A (en) * 2011-07-06 2014-09-18 セレラント セラピューティクス インコーポレイテッド Megakaryocyte progenitor cells for platelet production
EP3381456A1 (en) 2011-12-02 2018-10-03 Fate Therapeutics, Inc. Improved methods for treating ischemia
CA2857640C (en) 2011-12-02 2021-11-16 Fate Therapeutics, Inc. Enhanced stem cell composition
WO2013184809A1 (en) * 2012-06-05 2013-12-12 The Regents Of The University Of California Methods and compositions for the rapid production of retinal pigmented epithelial cells from pluripotent cells
EP2968416A4 (en) 2013-03-15 2016-08-17 Fate Therapeutics Inc Cell potency assay for therapeutic potential
JP2021180620A (en) * 2020-05-18 2021-11-25 株式会社マイオリッジ Method for producing target cell, method for producing product with target cell, and serum-free medium
FR3128874A1 (en) * 2021-11-09 2023-05-12 Crossject Pharmaceutical solution of hydrocortisone for injection device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004681B1 (en) * 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
WO1992006178A1 (en) * 1990-10-05 1992-04-16 Systemix, Inc. Megakaryocyte and platelet growth, production and composition

Also Published As

Publication number Publication date
IL110755A (en) 2000-11-21
CA2168091A1 (en) 1995-03-02
SG52619A1 (en) 1998-09-28
JPH09505462A (en) 1997-06-03
EP0719326A1 (en) 1996-07-03
WO1995006112A1 (en) 1995-03-02
AU702871B2 (en) 1999-03-11
AU7674494A (en) 1995-03-21

Similar Documents

Publication Publication Date Title
IL110755A0 (en) In vito growth of neutrophil and megakaryocyte precursors in serum-free media
HK3996A (en) Diamond having multiple coatings methods for their manufacture and use of same
IL103477A0 (en) Office and like chairs
EP0783841A4 (en) Filter medium and cigarette filter made with the use of the same
IL101943A0 (en) Structure,production and use of heregulin
ZA9210123B (en) Coated abrasive article and method of making same
AU5433494A (en) Injector and use of the same
EP0747169A3 (en) Abrasive articles and methods of making same
AU6125396A (en) Serum-free media for primitive hematopoietic cells and metho ds of use thereof
EP0554374A4 (en) Production and use of tracheal antimicrobial peptides
GB2271884B (en) Solenoids and methods of making solenoids
ZA929127B (en) Quinoline-3-carboxamides their manufacture and use
ZA919259B (en) Active fragments of fibroblast growth factor
EP0728011A4 (en) Growth factor compositions, preparation and use
ZA929128B (en) Hydroxypyridonecarboxamides their manufacture and use
AU3828195A (en) Analogs of acidic fibroblast growth factor having enhanced stability and biological activity
AU3555993A (en) Antibiotic preparation and use of the same in plants
EP0796322A4 (en) Production and use of human and plant methyltransferases
AU1880792A (en) Benzothiazepinones and their use as anticonvulsants
AU2062497A (en) Antisense interleukin 10 and methods of use
AU1838295A (en) High-affinity ligands of basic fibroblast growth factor and thrombin
GB9602721D0 (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis
EP0553772A3 (en) Bed and spring-mattress
AU7112194A (en) Inhibition of basic fibroblast growth factor with oligonculeotides
AU4573693A (en) Article serving as bed and seat

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees